During the past decade, Pasqua Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pasqua Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "University of Waterloo" with 2 trials sponsored, "Clinical Evaluation Research Unit at Kingston General Hospital" with 1 trials sponsored and "Hamilton Health Sciences Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pasqua Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Canadian Blood Services" with 1 trials as a collaborator, "Canadian Critical Care Trials Group" with 1 trials as a collaborator, "Canadian Frailty Network" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Pasqua Hospital" are "Alzheimer Disease" (4 trials), "Acute Care Medical" (1 trials), "Alzheimer's Disease" (1 trials), "COVID-19" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Pasqua Hospital" in a lesser frequency.

Most popular intervention types in "Pasqua Hospital" are "Drug" (7 trials), "Other" (3 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "BI 409306" (1 trials), "Convalescent plasma" (1 trials), "Donepezil" (1 trials), "Estrogen Antagonists" (1 trials) and "Integrated Nutrition Pathway for Acute Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pasqua Hospital" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pasqua Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Pasqua Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pasqua Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".